FREE Membership Sign in

MENU

JavaScript is disabled in your browser.

In order visualise this page, please follow these steps.

Insurers’ association provides feedback on drug policy work

Visibility360, PDF version to share

By Kate McCaffery | May 1, 2023, 10:59 a.m.

Flash | CANADIAN LIFE AND HEALTH INSURANCE ASSOCIATION (CLHIA) | Distribution | Regulation | Analytic | Medication

Photo: Unsplash

Feedback states Health Canada’s chosen regulatory model increases risk to drug plans.

This article is reserved to PRO Level subscribers

Discover the PRO Level

Advertisement

The most popular in Health

Health and well-being: A gap between workers and employers

Prominent economist and policy expert discuss coming long term care concerns

Research and Markets publishes global generic drug report

Make your business shine with Visibility360!

Get a PDF version to share in your networks.

I'm interested

Headlines

Desjardins’ income falls 24 per cent in first quarter

Manulife managers focus on conditions challenging typical portfolio construction

Denis Ricard elected industry association chair

Advertisement

Related topics …

Flash

Manulife managers focus on conditions challenging typical portfolio construction

Great-West Lifeco sells Putnam to Franklin Templeton

Intact’s acquisitions team ready for more deals

Regulators warn advisors and investors alike about targeted impersonation schemes

CANADIAN LIFE AND HEALTH INSURANCE ASSOCIATION (CLHIA)

Denis Ricard elected industry association chair

Interest rates propel UV Insurance's profit in 2022

Insurance and securities regulators jointly publish total cost reporting rules

Association comments on National Adaptation Strategy

Distribution

Assuris boosts policyholder protection levels

Firms join forces to advocate for single digital identity

Company launches specialized conversational agent in the insurance field

Investment Funds Institute of Canada prepares for annual Operations Day

Regulation

Actuaries’ association publishes resource for practitioners new to risk management

Conflicts of interest highlighted in British Columbia compliance review

Researcher looks at the potential consequences of Bill C-228

Ontario regulator seeks applicants for investor advisory panel

Analytic

Desjardins’ income falls 24 per cent in first quarter

Manulife Investment Management share investment outlook

Commissions advocate for artificial intelligence guardrails

Canada Pension Plan annualized return hits 10 per cent over 10 years

Medication

Prominent economist and policy expert discuss coming long term care concerns

Research and Markets publishes global generic drug report

Manulife says economy is straining employee mental health and employer bottom lines

Beneva adds pharmacogenomic testing to disability treatment plans